Therapeutically reprogrammed nutrient signalling enhances nanoparticulate albumin bound drug uptake and efficacy in KRAS-mutant cancer
Ran Li, Thomas S.C. Ng, Stephanie J. Wang, Mark Prytyskach, Christopher B. Rodell, Hannes Mikula, Rainer H. Köhler, Michelle A. Garlin, Douglas A. Lauffenburger, Sareh Parangi, Daniela M. Dinulescu, Nabeel Bardeesy, Ralph Weissleder, Miles A. Miller
Topics & Concepts
MutantKRASDrugCancerCancer researchCancer drugsSignallingAlbuminChemistryCell biologyBiologyPharmacologyMutationBiochemistryGeneGeneticsMetabolism, Diabetes, and CancerCancer, Hypoxia, and MetabolismCancer-related Molecular Pathways